Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Although Mdm2-mediated ubiquitination is essential for both degradation and nuclear export of p53, the molecular basis for the differential effects of Mdm2 remains unknown. Here we show that low levels of Mdm2 activity induce monoubiquitination and nuclear export of p53, whereas high levels promote p53's polyubiquitination and nuclear degradation. A p53-ubiquitin fusion protein that mimics monoubiquitinated p53 was found to accumulate in the cytoplasm in an Mdm2-independent manner, indicating that monoubiquitination is critical for p53 trafficking. These results clarify the nature of ubiquitination-mediated p53 regulation and suggest that distinct mechanisms regulate p53 function in accordance with the levels of Mdm2 activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“proteasome inhibition by ALLN stabilizes p53 mainly in the nucleus of RKO cancer cells, whereas cytoplasmic p53 accumulates to a far lower extent”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Interestingly, although p53 nuclear import is negatively regulated by ubiquitin modification, p53 nuclear export as well as translocation of cytoplasmic p53 to mitochondria are positively regulated by ubiquitin.23,37,38”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Interestingly, although p53 nuclear import is negatively regulated by ubiquitin modification, p53 nuclear export as well as translocation of cytoplasmic p53 to mitochondria are positively regulated by ubiquitin.23,37,38”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Additionally, mono-ubiquitination of p53 can facilitate export of p53 from the nucleus to the cytoplasm, thereby inhibiting its role as a transcription factor [110,111].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [111]
In the citing paper
“However, proteasome-dependent degradation of nuclear p53 can also effectively prevent its transactivation function [111,112], suggesting monoubiquitylation of cytoplasmic p53 is required for other processes.”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [111]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,031
Self-citationStommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738
Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., & Benchimol, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00193-4 · Cited by 722
Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study
Lev Bar-Or, R., Maya, R., Segel, L. A., Alon, U., Levine, A. J., & Oren, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210171597 · Cited by 588
Cited by
Komander, D., & Rape, M. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060310-170328 · Cited by 3,679
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610
Self-citationPost-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
“Although the significance is not yet clear, recent data indicate that MONOUBIQUITYLATION might act as a signal in nuclear export for p53, and that different levels of MDM2 can induce both mono- and POLYUBIQUITYLATION in a dose-dependent manner, so determining the fate of p53 (Ref”
Backgroundp53 ubiquitination: Mdm2 and beyond
Brooks, C. L., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.020 · Cited by 924
“Mdm2 was recently found to differentially catalyze monoubiquitination and polyubiquitination of p53 in a dosage-dependent manner (Li et al., 2003).”
BackgroundSelf-citationStressing the role of FoxO proteins in lifespan and disease
van der Horst, A., & Burgering, B. M. T. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2190 · Cited by 759
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting
Hernández Borrero, L. J., & El-Deiry, W. S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188556 · Cited by 748
Ubiquitination regulates PTEN nuclear import and tumor suppression
Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748
A dynamic role of HAUSP in the p53-Mdm2 pathway
Li, M., Brooks, C. L., Kon, N., & Gu, W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00157-1 · Cited by 679
Self-citationUSP10 Regulates p53 Localization and Stability by Deubiquitinating p53
Yuan, J., Luo, K., Zhang, L., Cheville, J. C., & Lou, Z. (2010) · Cell · doi:10.1016/j.cell.2009.12.032 · Cited by 637
“Localizes in the Cytoplasm and Counteracts Mdm2 Action Previous studies suggest that ubiquitination of p53 by Mdm2 could induce p53 translocation from nucleus to cytoplasm (Boyd et al., 2000; Geyer et al., 2000; Li et al., 2003; Stommel et al., 1999).”
IAPs, RINGs and ubiquitylation
Vaux, D. L., & Silke, J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1621 · Cited by 610
Drug discovery in the ubiquitin–proteasome system
Nalepa, G., Rolfe, M., & Harper, J. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2056 · Cited by 608
Reactivation of the p53 Tumor Suppressor Pathway by a Stapled p53 Peptide
Bernal, F., Tyler, A. F., Korsmeyer, S. J., Walensky, L. D., & Verdine, G. L. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0693587 · Cited by 556
FoxO1 protects against pancreatic β cell failure through NeuroD and MafA induction
Kitamura, Y. I., Kitamura, T., Kruse, J.-P., Raum, J. C., Stein, R., Gu, W., & Accili, D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.08.004 · Cited by 556
Self-citationThe deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network
Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07290 · Cited by 548
ARF-BP1/Mule Is a Critical Mediator of the ARF Tumor Suppressor
Chen, D., Kon, N., Li, M., Zhang, W., Qin, J., & Gu, W. (2005) · Cell · doi:10.1016/j.cell.2005.03.037 · Cited by 544
Self-citationCoping with stress: multiple ways to activate p53
Horn, H. F., & Vousden, K. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210263 · Cited by 522
Molecular Linkage Between the Kinase ATM and NF-κB Signaling in Response to Genotoxic Stimuli
Wu, Z.-H., Shi, Y., Tibbetts, R. S., & Miyamoto, S. (2006) · Science · doi:10.1126/science.1121513 · Cited by 515
ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins
Villarroya-Beltri, C., Baixauli, F., Mittelbrunn, M., Fernández-Delgado, I., Torralba, D., Moreno-Gonzalo, O., Baldanta, S., Enrich, C., Guerra, S., & Sánchez-Madrid, F. (2016) · Nature Communications · doi:10.1038/ncomms13588 · Cited by 491
Targeting Proteins for Destruction by the Ubiquitin System: Implications for Human Pathobiology
Schwartz, A. L., & Ciechanover, A. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.051208.165340 · Cited by 492
Posttranslational Modification of p53: Cooperative Integrators of Function
Meek, D. W., & Anderson, C. W. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000950 · Cited by 483
“p53 undergoes several other modifications that occur on lysine residues, including monoubiquitylation (Li et al. 2003; Nie et al. 2007; Carter and Vousden 2008), conjugation of ubiquitin chains through lysine 63 (K63) of ubiquitin (Laine et al. 2006), sumoylation by SUMO-1 and SUMO-2/3 (Gostissa et…”
BackgroundTranscription-independent pro-apoptotic functions of p53
Moll, U. M., Wolff, S., Speidel, D., & Deppert, W. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.007 · Cited by 468
The p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450
“However, proteasome-dependent degradation of nuclear p53 can also effectively prevent its transactivation function [111,112], suggesting monoubiquitylation of cytoplasmic p53 is required for other processes.”
BackgroundRegulating tumor suppressor genes: post-translational modifications
Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449
“Further, MDM2 mediates the nuclear export of p53.(266) Moreover, when p53 is ubiquitinated by MDM2, it cannot be acetylated by p300/ CBP, and, therefore, rapid proteasome-mediated degradation takes place.”
BackgroundYin Yang 1 Is a Negative Regulator of p53
Sui, G., Affar, E. B., Shi, Y., Brignone, C., Wall, N. R., Yin, P., Donohoe, M., Luke, M. P., Calvo, D., Grossman, S. R., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.004 · Cited by 424
A complex barcode underlies the heterogeneous response of p53 to stress
Murray-Zmijewski, F., Slee, E. A., & Lu, X. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2451 · Cited by 420
Ubiquitin and ubiquitin-like proteins in cancer pathogenesis
Hoeller, D., Hecker, C.-M., & Dikic, I. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1994 · Cited by 408
“If MDM2 is expressed at a low level it will primarily monoubiquitylate p53, which leads to the nuclear export but not to the proteasomal degradation of p53 (Ref”
Backgroundp53 modifications: exquisite decorations of the powerful guardian
Liu, Y., Tavana, O., & Gu, W. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz060 · Cited by 392
Self-citationIntracellular signaling during skeletal muscle atrophy
Kandarian, S. C., & Jackman, R. W. (2006) · Muscle & Nerve · doi:10.1002/mus.20442 · Cited by 393
The spatial and temporal organization of ubiquitin networks
Grabbe, C., Husnjak, K., & Dikic, I. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3099 · Cited by 365
Mdm2-mediated ubiquitylation: p53 and beyond
Marine, J.-C., & Lozano, G. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.68 · Cited by 354
Protein composition of the intranuclear inclusions of FXTAS
Iwahashi, C. K., Yasui, D. H., An, H.-J., Greco, C. M., Tassone, F., Nannen, K., Babineau, B., Lebrilla, C. B., Hagerman, R. J., & Hagerman, P. J. (2006) · Brain · doi:10.1093/brain/awh650 · Cited by 359
“Indeed, such proteins may not be polyubiquitinated, but rather mono-ubiquitinated, and would thus be less likely to be substrates for proteasomal degradation (Ciechanover, 1998; Hagerman et al., 2003; Li et al., 2003).”
BackgroundA plausible model for the digital response of p53 to DNA damage
Ma, L., Wagner, J., Rice, J. J., Hu, W., Levine, A. J., & Stolovitzky, G. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501352102 · Cited by 356
Transcription-independent p53 apoptosis: an alternative route to death
Speidel, D. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.10.002 · Cited by 356
Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4
Marine, J.-C., Francoz, S., Maetens, M., Wahl, G., Toledo, F., & Lozano, G. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401912 · Cited by 352
Ubiquitin and Ubiquitin-Like Proteins in Protein Regulation
Herrmann, J., Lerman, L. O., & Lerman, A. (2007) · Circulation Research · doi:10.1161/01.res.0000264500.11888.f0 · Cited by 332
p53 Acetylation: Regulation and Consequences
Reed, S., & Quelle, D. (2014) · Cancers · doi:10.3390/cancers7010030 · Cited by 332
“Specifically, high levels of Mdm2 activity normally lead to polyubiquitylation and degradation of p53, but at low levels Mdm2 induces p53 mono-ubiquitylation, which inhibits DNA binding and promotes the nuclear export of p53 [132–134].”
BackgroundSmall molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells
Yang, Y., Ludwig, R. L., Jensen, J. P., Pierre, S. A., Medaglia, M. V., Davydov, I. V., Safiran, Y. J., Oberoi, P., Kenten, J. H., Phillips, A. C., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.029 · Cited by 322
Clinical Overview of MDM2/X-Targeted Therapies
Burgess, A., Chia, K. M., Haupt, S., Thomas, D., Haupt, Y., & Lim, E. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00007 · Cited by 315
“Despite the similarity in the N-terminal p53-binding domain of MDM2 and MDMX, most of these small molecule inhibitors bind with significantly less avidity to MDMX and are therefore primarily MDM2 specific (12).”
BackgroundKaryopherins: from nuclear-transport mediators to nuclear-function regulators
Mosammaparast, N., & Pemberton, L. F. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.09.004 · Cited by 316
The p53 family and programmed cell death
Pietsch, E. C., Sykes, S. M., McMahon, S. B., & Murphy, M. E. (2008) · Oncogene · doi:10.1038/onc.2008.315 · Cited by 315
“Consistent with this premise, p53 poly-ubiquitylation acts as a protein destruction signal, whereas monoubiquitylation of p53 promotes nuclear export and mitochondrial localization (Li et al., 2003; Marchenko et al., 2007).”
BackgroundFeng, J., Tamaskovic, R., Yang, Z., Brazil, D. P., Merlo, A., Hess, D., & Hemmings, B. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404936200 · Cited by 294
Planchon, S. M., Waite, K. A., & Eng, C. (2008) · Journal of Cell Science · doi:10.1242/jcs.022459 · Cited by 293
The multiple levels of regulation by p53 ubiquitination
Lee, J. T., & Gu, W. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.77 · Cited by 289
“As previously described, low levels of Mdm2 have been shown to induce mono-ubiquitination and target p53 for nuclear export.(18) p53 C-terminal ubiquitination mediated by Mdm2 was identified to be essential for the nuclear export.”
Self-citationRegulation of the p53 response and its relationship to cancer
Meek, D. W. (2015) · Biochemical Journal · doi:10.1042/bj20150517 · Cited by 288
Monoubiquitylation promotes mitochondrial p53 translocation
Marchenko, N. D., Wolff, S., Erster, S., Becker, K., & Moll, U. M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601560 · Cited by 286
“…(called UbKO, for ubquitin knockout), which generates mainly monoubiquitylated p53 (Figure 3B, right, Figure 3D top; Supplementary Figure 1B; Li et al, 2003), promoted this process even better than Ubwt (Figure 3A, compare lanes 5 and 6), which generates both poly- and monoubiquitylated p53…”
BackgroundInfluentialNucleocytoplasmic shuttling of signal transducers
Xu, L., & Massagué, J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1331 · Cited by 272
Lysine‐63‐linked ubiquitination is required for endolysosomal degradation of class I molecules
Duncan, L. M., Piper, S., Dodd, R. B., Saville, M. K., Sanderson, C. M., Luzio, J. P., & Lehner, P. J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601056 · Cited by 274
“The HLA-A*0201 gene, with its three cytoplasmic tail lysines mutated to arginine, was fused to a mutant, lysine-less ubiquitin (HLA-A2K0UbK0) ( Li et al, 2003 ).”
BackgroundRegulation of autophagy by stress-responsive transcription factors
Pietrocola, F., Izzo, V., Niso-Santano, M., Vacchelli, E., Galluzzi, L., Maiuri, M. C., & Kroemer, G. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.05.008 · Cited by 268
Multisite protein modification and intramolecular signaling
Yang, X.-J. (2005) · Oncogene · doi:10.1038/sj.onc.1208173 · Cited by 266
Osteoblast differentiation and skeletal development are regulated by Mdm2–p53 signaling
Lengner, C. J., Steinman, H. A., Gagnon, J., Smith, T. W., Henderson, J. E., Kream, B. E., Stein, G. S., Lian, J. B., & Jones, S. N. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200508130 · Cited by 265
“In addition, Mdm2 can function as an E3 ligase to coordinate the ubiquitination of p53 (Honda et al., 1997) and can induce the degradation of p53 by the 26S proteasome (Haupt et al., 1997; Kubbutat et al., 1997; Li et al., 2003).”
BackgroundMdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo
Francoz, S., Froment, P., Bogaerts, S., De Clercq, S., Maetens, M., Doumont, G., Bellefroid, E., & Marine, J.-C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508476103 · Cited by 260
Tisato, V., Voltan, R., Gonelli, A., Secchiero, P., & Zauli, G. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0500-5 · Cited by 256
“In particular, in the presence of low levels of MDM2, it is likely that P53 undergoes to MDM2-mediated monoubiquitination and cytoplasmic translocation, while in the presence of stressed conditions MDM2 activities are high and there is a preferential poly-ubiquitination of P53 leading to degradation in the nucleus [52…”
BackgroundMechanism of p53 stabilization by ATM after DNA damage
Cheng, Q., & Chen, J. (2010) · Cell Cycle · doi:10.4161/cc.9.3.10556 · Cited by 248
Le Cam, L., Linares, L. K., Paul, C., Julien, E., Lacroix, M., Hatchi, E., Triboulet, R., Bossis, G., Shmueli, A., Rodriguez, M. S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.031 · Cited by 240
“Stimulation of Ub chain polymerization by Hdm2 was previously shown to depend on six lysines in the C terminus of human p53 (K370, K372, K373, K381, K382, and K386) (Krummel et al., 2005; Li et al., 2003; Nakamura et al., 2000; Rodriguez et al., 2000).”
InfluentialDNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway
Parrales, A., Ranjan, A., Iyer, S. V., Padhye, S., Weir, S. J., Roy, A., & Iwakuma, T. (2016) · Nature Cell Biology · doi:10.1038/ncb3427 · Cited by 239
Surf the Post-translational Modification Network of p53 Regulation
Gu, B., & Zhu, W.-G. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4283 · Cited by 235
The Nedd4-like family of E3 ubiquitin ligases and cancer
Chen, C., & Matesic, L. E. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9091-x · Cited by 228
The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53
Higashitsuji, H., Higashitsuji, H., Itoh, K., Sakurai, T., Nagao, T., Sumitomo, H., Masuda, T., Dawson, S., Shimada, Y., Mayer, R. J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.006 · Cited by 228
Regulation of Wnt/β-catenin signaling by posttranslational modifications
Gao, C., Xiao, G., & Hu, J. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-13 · Cited by 226
“Sumoylation or ubiquitination fusion protein methodology is a powerful complementary strategy for mutant approach that is used to discriminate between the consequence of lacking substrate sumoylation and conformational change-related artifacts [211-215].”
BackgroundC-terminal modifications regulate MDM2 dissociation and nuclear export of p53
Carter, S., Bischof, O., Dejean, A., & Vousden, K. H. (2007) · Nature Cell Biology · doi:10.1038/ncb1562 · Cited by 225
“Previous studies have suggested that although polyubiquitination is required for degradation, monoubiquitination of p53 is sufficient for nuclear expor”
BackgroundThe ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications
Burger, A. M., & Seth, A. K. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.006 · Cited by 224
Regulation of Human p53 Activity and Cell Localization by Alternative Splicing
Ghosh, A., Stewart, D., & Matlashewski, G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.7987-7997.2004 · Cited by 221
“It has recently been shown that monoubiquitination of p53 results in nuclear export and that polyubiquitination of p53 results in nuclear export and proteasome-mediated degradation ( 12 ).”
BackgroundInfluentialp53-family proteins and their regulators: hubs and spokes in tumor suppression
Collavin, L., Lunardi, A., & Del Sal, G. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2010.35 · Cited by 220
Shi, D., & Gu, W. (2012) · Genes & Cancer · doi:10.1177/1947601912455199 · Cited by 191
“The distinction between monoubiquitination and polyubiquitination of p53 adds additional complexity to its regulation.(38) MDM2 possess E3 ligase activity and prefers to catalyze monoubiquitination of p53 when the amount of MDM2 protein is limited in cells.”
BackgroundInfluentialSelf-citationActivating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination
Yan, C., Lu, D., Hai, T., & Boyd, D. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600712 · Cited by 214
“Interestingly, decreased p53 ubiquitination in the nucleus may have another consequence in light of recent findings (Joseph et al, 2003; Li et al, 2003) of p53 turnover by nuclear proteasomes.”
BackgroundMethodInfluentialYY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress
Grönroos, E., Terentiev, A. A., Punga, T., & Ericsson, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402283101 · Cited by 210
Ma-Lauer, Y., Carbajo-Lozoya, J., Hein, M. Y., Müller, M. A., Deng, W., Lei, J., Meyer, B., Kusov, Y., von Brunn, B., Bairad, D. R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603435113 · Cited by 210
“High levels of MDM2 induce polyubiquitination and degradation of p53, whereas low levels of MDM2 lead to monoubiquitination and nuclear export of p53 (23).”
BackgroundWeighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics
Kirkpatrick, D. S., Denison, C., & Gygi, S. P. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-750 · Cited by 209
“The modification of substrates by multiple mono-ubiquitins has been reported to have distinct effects on the localization of proteins such as p53 (ref”
BackgroundDirect interaction of FANCD2 with BRCA2 in DNA damage response pathways
Hussain, S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh135 · Cited by 208
“However, recruitment of FANCD2 into nuclear foci has been shown to be dependent on its ubiquitination (18) and this is consistent with the proposed role of monoubiquitination in protein trafficking (39).”
Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis.
Wang, Q., Ma, S., Song, N., Li, X., Liu, L., Yang, S., Ding, X., Shan, L., Zhou, X., Su, D., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85747 · Cited by 206
Ribosomal Protein S7 Is Both a Regulator and a Substrate of MDM2
Zhu, Y., Poyurovsky, M. V., Li, Y., Biderman, L., Stahl, J., Jacq, X., & Prives, C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.07.014 · Cited by 206
“M in which a p53-ubiquitin fusion protein was utilized (Carter et al., 2007; Li et al., 2003; Sasaki et al., 2007).”
FBXO11 Promotes the Neddylation of p53 and Inhibits Its Transcriptional Activity
Abida, W. M., Nikolaev, A., Zhao, W., Zhang, W., & Gu, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609001200 · Cited by 203
Self-citationSLIM Is a Nuclear Ubiquitin E3 Ligase that Negatively Regulates STAT Signaling
Tanaka, T., Soriano, M. A., & Grusby, M. J. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.008 · Cited by 200
The nuclear ubiquitin-proteasome system
von Mikecz, A. (2006) · Journal of Cell Science · doi:10.1242/jcs.03008 · Cited by 200
“Subsequent work indicates that the level of Mdm2 activity differentially controls the fate of p53: low-level Mdm2 activity induces mono-ubiquitylation and nuclear export of p53, whereas high Mdm2 activity promotes polyubiquitylation of p53 and its degradation in the nucleus (Li et al., 2003).”
BackgroundMDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and Degradation
Fu, W., Ma, Q., Chen, L., Li, P., Zhang, M., Ramamoorthy, S., Nawaz, Z., Shimojima, T., Wang, H., Yang, Y., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901758200 · Cited by 201
Olsson, A., Manzl, C., Strasser, A., & Villunger, A. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402196 · Cited by 200
“sumoylation, promoting nuclear export of p53, whereas high levels promote poly-ubiquitination and proteasomal degradation of p53.(91,92) It has therefore been proposed that MDM2 keeps p53 in check by mono-ubiqitination and nuclear export”
BackgroundCellular UV damage responses—Functions of tumor suppressor p53
Latonen, L., & Laiho, M. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.04.003 · Cited by 197
“The monoubiquitination of p53 leads to p53 nuclear export, whereas polyubiquitination activates p53 proteasomal degradation [88].”
Mashtalir, N., Daou, S., Barbour, H., Sen, N. N., Gagnon, J., Hammond-Martel, I., Dar, H. H., Therrien, M., & Affar, E. B. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.002 · Cited by 195
“UBE2O could be imported into the nucleus to ubiquitinate BAP1 and promote its ubiquitin-mediated nuclear export as observed for other proteins (Groulx and Lee, 2002; Li et al., 2003).”
BackgroundClassification, Expression Pattern, and E3 Ligase Activity Assay of Rice U-Box-Containing Proteins
Zeng, L.-R., Park, C. H., Venu, R. C., Gough, J., & Wang, G.-L. (2008) · Molecular Plant · doi:10.1093/mp/ssn044 · Cited by 195
Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1
Sun, X., Challagundla, K. B., & Dai, M. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.434 · Cited by 195
“USP7 (also called HAUSP) deubiquitinates p53, leading to p53 stabilization and activation (Li et al , 2002).”
Structure-guided development of a potent and selective non-covalent active-site inhibitor of USP7.
Lamberto, I., Liu, X., Seo, H.-S., Schauer, N. J., Iacob, R. E., Hu, W., Das, D., Mikhailova, T., Weisberg, E. L., Engen, J. R., et al. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.09.003 · Cited by 192
“…changes, complexation with other proteins,(Ea et al., 2006; Wu et al., 2006) susceptibility to addition of other post-translation modifications (PTM) including phosphorylation and acetylation,(Hunter, 2007; Zhang et al., 2008; Zhao et al., 2008) and cellular localization(Li et al., 2003).”
BackgroundPavlopoulos, E., Trifilieff, P., Chevaleyre, V., Fioriti, L., Zairis, S., Pagano, A., Malleret, G., & Kandel, E. R. (2011) · Cell · doi:10.1016/j.cell.2011.09.056 · Cited by 191
“This approach has been used to study protein modification by ubiquitin, as Ub fusion proteins have been shown to mimic ubiquitination in some instances (Qian et al., 2002; Li et al., 2003; Carter and Vousden, 2008).”
Outcomes of p53 activation - spoilt for choice
Vousden, K. H. (2006) · Journal of Cell Science · doi:10.1242/jcs.03293 · Cited by 189
“The amount of MDM2 available appears to be critical in determining the outcome: mono-ubiquitylation of p53 by low levels of MDM2 allows nuclear export, whereas higher levels of MDM2 result in poly-ubiquitylation and degradation of p53 by the proteasome (Li et al., 2003).”
BackgroundComplicating the complexity of p53
Yee, K. S., & Vousden, K. H. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi122 · Cited by 188
Krummel, K. A., Lee, C. J., Toledo, F., & Wahl, G. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503068102 · Cited by 187
Redox Regulation of p53, Redox Effectors Regulated by p53: A Subtle Balance
Maillet, A., & Pervaiz, S. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4434 · Cited by 186
“The p53 protein can be regulated by different post-translational modifications such as phosphorylation of serine and/or threonine residues (39), acetylation (67), ubiquitylation (54), or sumoylation (33) of lysine residues.”
Brooks, C. L., & Gu, W. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.022 · Cited by 186
“Interestingly, monoubiquitination of p53 induces nuclear export in an Mdm2 dose-dependent manner [16,41].”
BackgroundSelf-citationThe roles of E3 ubiquitin ligases in cancer progression and targeted therapy
Sampson, C., Wang, Q., Otkur, W., Zhao, H., Lu, Y., Liu, X., & Piao, H. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1204 · Cited by 182
Boutet, S. C., Disatnik, M.-H., Chan, L. S., Iori, K., & Rando, T. A. (2007) · Cell · doi:10.1016/j.cell.2007.05.044 · Cited by 179
“As a test of the sufficiency of monoubiquitination to drive Pax3 degradation, the stability of each of the Pax3 mutants was assessed when expressed as fusion proteins with Ub, a modification that does not render protein susceptible to proteasomal degradation nonspecifically (Li et al., 2003).”
InfluentialYamashita, M., Shinnakasu, R., Asou, H., Kimura, M., Hasegawa, A., Hashimoto, K., Hatano, N., Ogata, M., & Nakayama, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502333200 · Cited by 176
Role of Ubiquitin Ligases and the Proteasome in Oncogenesis: Novel Targets for Anticancer Therapies
Micel, L. N., Tentler, J. J., Smith, P. G., & Eckhardt, G. S. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.0958 · Cited by 176
The regulation of MDM2 oncogene and its impact on human cancers
Zhao, Y., Yu, H., & Hu, W. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt147 · Cited by 173
“High levels of MDM2 activity promote polyubiquitination and degradation of p53, while low levels of MDM2 activity induce mono-ubiquitination and nuclear exportation of p53 [12].”
BackgroundThe Hypoxia-controlled FBXL14 Ubiquitin Ligase Targets SNAIL1 for Proteasome Degradation
Viñas-Castells, R., Beltran, M., Valls, G., Gómez, I., García, J. M., Montserrat-Sentís, B., Baulida, J., Bonilla, F., de Herreros, A. G., & Díaz, V. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.065995 · Cited by 170
Gajjar, M., Candeias, M. M., Malbert-Colas, L., Mazars, A., Fujita, J., Olivares-Illana, V., & Fåhraeus, R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.016 · Cited by 170
“These results implicate a route for therapeutic in l pathway (Honda et al., 1997; Li et al., 2003).”
BackgroundLimiting the power of p53 through the ubiquitin proteasome pathway
Pant, V., & Lozano, G. (2014) · Genes & Development · doi:10.1101/gad.247452.114 · Cited by 167
“For example, low Mdm2 levels induce monoubiquitination and nuclear export of p53, while higher levels promote its polyubiquitination and degradation (Li et al. 2003).”
BackgroundThe role of ubiquitin modification in the regulation of p53
Hock, A. K., & Vousden, K. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.022 · Cited by 168
CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53
Shi, D., Pop, M. S., Kulikov, R., Love, I. M., Kung, A. L., & Grossman, S. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904305106 · Cited by 161
“In stressed cells, the induction of MDM2 expression by activated p53, can specifically increase the abundance of polyubiquitinated p53 adducts (8).”
BackgroundTranscription-independent ARF regulation in oncogenic stress-mediated p53 responses
Chen, D., Shan, J., Zhu, W.-G., Qin, J., & Gu, W. (2010) · Nature · doi:10.1038/nature08820 · Cited by 160
Self-citationRegulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in Vivo
Saville, M. K., Sparks, A., Xirodimas, D. P., Wardrop, J., Stevenson, L. F., Bourdon, J.-C., Woods, Y. L., & Lane, D. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403362200 · Cited by 158
Chao, C. C. ‐. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.015 · Cited by 167
Metadata
- Authors
- Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W.
- Affiliations
- Columbia University (US)
- Corresponding author
- Gu, Wei
- Venue
- Science
- Published
- 2003-12-12
- Volume
- 302
- Issue
- 5652
- Pages
- 1972-1975
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050745715
- Cited by
- 804
- References
- 30
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 21 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 28 · 2019: 22 · 2018: 22 · 2017: 24 · 2016: 32 · 2015: 34 · 2014: 45 · 2013: 37 · 2012: 38
- FWCI
- 19.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, monoubiquitination, polyubiquitination, ubiquitination, p53 degradation, tumor suppressor regulation
- MeSH terms
- Animals, Cell Nucleus, Cells, Cultured, Cytoplasm, Humans, Mutation, Nuclear Proteins, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Transfection, Tumor Suppressor Protein p53, Mice, Knockout, Protein Transport, Active Transport, Cell Nucleus, Ubiquitin, Cell Line, Tumor, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.